Role of Model‐Informed Drug Development in Pediatric Drug Development, Regulatory Evaluation, and Labeling
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Model‐Informed Drug Development in Pediatric Drug Development, Regulatory Evaluation, and Labeling
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL PHARMACOLOGY
Volume 59, Issue S1, Pages -
Publisher
Wiley
Online
2019-09-10
DOI
10.1002/jcph.1478
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Model-Informed Drug Development: Current U.S. Regulatory Practice and Future Considerations
- (2019) Yaning Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Model-informed drug development approach supporting approval of the 4-week (Q4W) dosing schedule for nivolumab (Opdivo) across multiple indications: a regulatory perspective
- (2019) Y Bi et al. ANNALS OF ONCOLOGY
- Physiologically Based Pharmacokinetic Modeling in Regulatory Science: An Update From the U.S. Food and Drug Administration’s Office of Clinical Pharmacology
- (2018) Manuela Grimstein et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Bioequivalence Comparison of Pediatric Dasatinib Formulations and Elucidation of Absorption Mechanisms Through Integrated PBPK Modeling
- (2018) Shruthi Vaidhyanathan et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Esomeprazole FDA Approval in Children With GERD
- (2017) Justin C. Earp et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Failed Pediatric Drug Development Trials
- (2015) JD Momper et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacology and the Catalysis of Regulatory Science: Opportunities for the Advancement of Drug Development and Evaluation
- (2013) I Zineh et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Adolescent Dosing and Labeling Since the Food and Drug Administration Amendments Act of 2007
- (2013) Jeremiah D. Momper et al. JAMA Pediatrics
- Pediatric Information in Drug Product Labeling
- (2012) Debbie Avant JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions
- (2011) Joo Yeon Lee et al. CLINICAL PHARMACOKINETICS
- Pharmacokinetics of Antiretroviral Drug Varies With Formulation in the Target Population of Children With HIV-1
- (2011) P Kasirye et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clarification on Precision Criteria to Derive Sample Size When Designing Pediatric Pharmacokinetic Studies
- (2011) Yaning Wang et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Clinical Pharmacology in the Adolescent Oncology Patient
- (2010) Gareth J. Veal et al. JOURNAL OF CLINICAL ONCOLOGY
- Mechanistic Basis of Using Body Size and Maturation to Predict Clearance in Humans
- (2009) Brian J. Anderson et al. Drug Metabolism and Pharmacokinetics
- Leveraging Prior Quantitative Knowledge to Guide Drug Development Decisions and Regulatory Science Recommendations: Impact of FDA Pharmacometrics During 2004-2006
- (2008) Yaning Wang et al. JOURNAL OF CLINICAL PHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started